Loading...
Loading...
Also known as: LL-37, hCAP-18, CAMP
Human antimicrobial peptide with broad-spectrum activity and immunomodulatory properties.
Benefits
6
Conditions
6
Evidence
Extensive in vitro research, preclinical models, limited human trials+ studies
Source
Human endogenous cathelicidin peptide, synthesized or recombinant
Gabriel Brain Score
Moderate
Human antimicrobial peptide with broad-spectrum activity and immunomodulatory properties.
Disrupts bacterial, fungal, and viral membranes, neutralizes LPS endotoxins, inhibits biofilm formation, chemotactic for immune cells, promotes wound healing and angiogenesis, modulates inflammatory response.
* Dosing should be individualized. Always consult with a qualified healthcare practitioner.
Extensive in vitro research, preclinical models, limited human trials
Well-characterized antimicrobial and immunomodulatory mechanisms. Deficiency linked to skin conditions like rosacea. Clinical trials limited but promising for wound care and infection control.
Broad class of innate immune peptides with antimicrobial, immunomodulatory, and wound-healing properties representing next-generation anti-infectives.
Family of small cationic antimicrobial peptides that form first line of innate immune defense.
Multifunctional iron-binding glycoprotein with antimicrobial, immunomodulatory, and anti-inflammatory properties.